Jonathan Zung
Corporate Officer/Principal at CURIS, INC.
Net worth: - $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Dentzer | M | 57 | 8 years | |
John Hohneker | M | 64 | 3 years | |
Diantha Duvall | F | 52 | 2 years | |
Martyn Greenacre | M | 82 | 24 years | |
Robert Martell | M | 61 | 13 years | |
David R. Bobbitt | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 7 years |
Mark W. Noel | M | 65 | 23 years | |
Marc Rubin | M | 69 | 14 years | |
Anne Borgman | M | 56 | 2 years | |
Kenneth Kaitin | M | 71 | 21 years | |
Dora Ferrari | F | - | 3 years | |
Kimberly Steinmann | M | - | 2 years | |
Mark D. Plinio | M | 57 | 3 years | |
Jonkheer Cédric van Rijckevorsel | M | 54 | 10 years | |
Nancy Soohoo | F | - | 21 years | |
Reinhard von Roemeling | M | - | 5 years | |
Cyril Janssen | M | 53 | 9 years | |
Rachel Blasbalg | F | - | 20 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ann Thorell | F | 56 | 1 years | |
David Epstein | M | 62 | 6 years | |
David Perry | M | 56 | 6 years | |
Steve Innaimo | M | - | 1 years | |
Luca Scavo | M | 57 | 1 years | |
Deborah Keller | F | 61 | 29 years | |
Mohammed Khoso Baluch | M | 66 | 8 years | |
Alice Dautry-Varsat | M | 74 | - | |
Rebecca Daniels Kush | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Tonya Williams | F | 50 | 1 years | |
David A. Evans | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | 3 years |
Nancy Simonian | M | 63 | 3 years | |
Peter John Fellner | M | 80 | 9 years | |
Frederic Roch Doliveux | M | 68 | 11 years | |
Eric Lang | M | - | 5 years | |
Jared M. Freedberg | M | 55 | 8 years | |
Kendra Sweeney | F | - | 2 years | |
Bob Dagher | M | 55 | 1 years | |
Iain Mcinnes | M | 59 | 2 years | |
Alain Bernard | M | 67 | 10 years | |
Xiaoli Liu | F | 49 | 3 years | |
James Harkness | M | 59 | 3 years | |
Pascale Richetta | M | 65 | 4 years | |
John D. Ratliff | M | 64 | - | |
Nicole O’Rourke | F | - | 7 years | |
Bharat Tewarie | M | - | 5 years | |
George Blackman | M | - | 9 years | |
Nicole Harmon | M | - |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | - |
Stephen J. Carriere | M | - | 2 years | |
Mark W. Bodmer | M | 69 | 4 years | |
Jose-Carlos Gutiérrez-Ramos | M | 61 | 1 years | |
Julie McHugh | F | 59 | 2 years | |
Heidi Hunter | F | 66 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 39 | 76.47% |
Belgium | 12 | 23.53% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Zung
- Personal Network